Alphapharm Pty Ltd v Merck & Co Inc

In the case of Alphapharm Pty Ltd v Merck & Co Inc, the parties were engaged in a dispute concerning the validity of a patent. The Federal Court of Australia was tasked with determining whether certain claims made by Alphapharm regarding the patent's utility could be summarily dismissed under section 31A of the Patents Act 1990 (Cth). Merck argued that the claims should be struck out as being untenable and lacking reasonable prospects of success. Alphapharm, on the other hand, contested this by arguing that the court should not construe the patent without expert evidence, particularly in relation to the utility of the patent.

The court had to decide whether the patent claims related to utility could be summarily dismissed under section 31A of the Patents Act, and whether expert evidence was necessary for the court to assess the validity of these claims. The court also considered whether the discovery of evidence on the issue of utility by Merck was appropriate at that stage of the proceedings. The court determined that without expert evidence, it was not appropriate to construe the patent or dismiss the claims regarding utility. It was noted that while expert evidence might eventually support Merck's position, such evidence was not before the court at the time of the motion.

The court ruled that the contentions of Alphapharm about inutility should not be dismissed without the benefit of expert evidence. Furthermore, the court held that even if such evidence existed, it was more appropriate to leave the determination of these issues to the trial. Therefore, the court declined to summarily dispose of any part of Alphapharm's claims at that stage. Finally, the court ordered that the parties submit minutes of order within seven days to give effect to the court's reasons.